SIO CAPITAL MANAGEMENT LLC
Q1 2026 Form 13-F
NEW YORK, NEW YORK
CIK 0001482416
· CRD 165989
· SEC-registered investment adviser
$697.3M Reported Value Total
SIO CAPITAL MANAGEMENT, LLC reports 6 total accounts under management (AUM). There are 6 discretionary accounts valued at $1,293,066,687, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
6 funds
· $864.7M gross asset value
Hedge Fund: $864.7M
Source: Form ADV filed 2026-03-18
Reported value
$697.3M
Quarter over quarter
-1.1%
Holdings
73
Top-10 concentration
45.1%
Key People
Form ADV owners & control persons
Michael Bernard Castor
MANAGING MEMBER
Judah Zvi Drillick
CHIEF EXECUTIVE OFFICER
Jin Woo Lee
CHIEF COMPLIANCE OFFICER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q1 2026 13F record
Q1 2026 13F filing summary
| Period of report | March 31, 2026 |
|---|---|
| Filed | May 14, 2026 |
| Form | 13F-HR |
| Reported value | $697.3M |
| Positions | 73 |
| Change in reported value | +9.7% |
| New positions | 22 |
| Exited positions | 14 |
| Position turnover | 41.4% |
| Top-10 concentration | 45.1% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
51 | $528.5M |
|
Q2 2026 13F
Filed Aug 14, 2026
|
57 | $604.3M |
|
Q1 2026 13F
Filed May 14, 2026
|
73 | $697.3M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
65 | $635.7M |
|
Q3 2025 13F
Filed Nov 13, 2025
|
51 | $395.2M |
|
Q2 2025 13F
Filed Aug 13, 2025
|
49 | $261.8M |
|
Q1 2025 13F
Filed May 15, 2025
|
53 | $335.8M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
51 | $355.4M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
38 | $252.2M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
46 | $369.5M |
|
Q1 2024 13F
Filed May 15, 2024
|
48 | $335.8M |
|
Q4 2023 13F
Filed Feb 13, 2024
|
39 | $439.2M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
52 | $323.1M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
41 | $393.2M |
|
Q1 2023 13F
Filed May 12, 2023
|
44 | $202.3M |
|
Q4 2022 13F
Filed Feb 13, 2023
|
41 | $270.4M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
43 | $314.7M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
59 | $266.2M |
|
Q1 2022 13F
Filed May 16, 2022
|
61 | $302.3M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
67 | $331.7M |
28 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q1 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | MMS MAXIMUS INC | $49.3M | 7.07% |
| 2 | WAY WAYSTAR HLDG CORP | $39.6M | 5.68% |
| 3 | ICLR ICON PLC | $33.9M | 4.86% |
| 4 | COR CENCORA INC | $31.7M | 4.55% |
| 5 | DNTH DIANTHUS THERAPEUTICS INC | $31.1M | 4.45% |
| 6 | AVR ANTERIS TECHNOLOGIES GLOBAL | $29.9M | 4.28% |
| 7 | CORT CORCEPT THERAPEUTICS INC | $27.2M | 3.9% |
| 8 | LIVN LIVANOVA PLC | $26.8M | 3.84% |
| 9 | TYRA TYRA BIOSCIENCES INC | $23.2M | 3.33% |
| 10 | CELC CELCUITY INC | $22.1M | 3.17% |
| 11 | GSK GSK PLC | $21.3M | 3.05% |
| 12 | ANIP ANI PHARMACEUTICALS INC | $20.4M | 2.93% |
| 13 | ABT ABBOTT LABORATORIES | $19.2M | 2.75% |
| 14 | EMBC EMBECTA CORP | $16.3M | 2.34% |
| 15 | ABVX ABIVAX SA | $15.1M | 2.17% |
| 16 | VIR VIR BIOTECHNOLOGY INC | $13.4M | 1.93% |
| 17 | HAE HAEMONETICS CORP MASS | $12.4M | 1.78% |
| 18 | SION SIONNA THERAPEUTICS INC | $11.8M | 1.69% |
| 19 | SNY SANOFI SA | $11.5M | 1.66% |
| 20 | RAPP RAPPORT THERAPEUTICS INC | $11.5M | 1.65% |
Values as reported on the Q1 2026 Form 13F. Every position is in the holdings table below.